| Micro-channel |
 |
|
|
|
|
|
| |
| Analysis of drug sales data in 22 key urban physical pharmacies |
| |
| Author：中國銘鉉 企劃部 Release Time：2017-8-29 12:06:14 Number Browse：737 |
| |
Medical network on August 29 - along with the medical and health system reform continued to deepen, state health control, implement zero price difference, drug prescription drugs outflow trend gradually clear, good medicine retail market in China policy.According to the data, the sales volume of pharmaceuticals in China's physical drug stores was 332.7 billion yuan in 2016, an increase of 8.1% year on year, and the market was in a rising state.
The proportion of drugs in key cities is high, about 23% nationwide
With the continuous deepening of the health care reform system, the national health insurance control fee, the drug zero-spread implementation, the trend of prescription drug outflow gradually becomes clear, the Chinese drug retail market welcomed the policy positive.According to the data, the sales volume of pharmaceuticals in China's physical drug stores was 332.7 billion yuan in 2016, an increase of 8.1% year on year, and the market was in a rising state.
22 key urban areas
Retail terminal drug sales of about sixty percent from the ground level above the city entities pharmacy, which covers six administrative region in China, north China, northeast China, east China, central China, southwest, northwest) of 22 key retail sales representative of the city, according to m, according to data from the network entities of the key cities for the pharmacy drug scale accounts for about 23% (see chart 1), has been a steady rise in sales.From 2013 to 2016, the total sales volume of pharmaceutical products in 22 key cities were above 60 billion yuan, and the price level was improved.In 2016, the growth of key urban drugs was 9.8%, higher than the national drug growth rate (8.1%), and the growth of key cities was greater, with the growth of central and south China and the west highlighted.
Figure 1. The ratio and growth trend of drug sales in the key urban entities in 2013-2016
Note: sales ratio = 22 key urban entity pharmacies sales/national physical drugstore sales
The proportion of drug sales rose, and the advantages of Chinese medicine were regional
Pharmaceutical industry increasingly fierce competition, in order to meet the industry development, the diversification of pharmacy positive development, the layout of the specialized medical services, the introduction of DTP model, slow disease management, in order to improve the competitive power.According to the data, the proportion of drug sales in China's physical pharmacies rose from 71.4% in 2015 to 72.6% in 2016, and the drug market expanded.In 2016, the total number of pharmacies in key cities was combined with 51.1 percent of the chemical drugs, and 48.9 percent of Chinese medicine (see figure 2).Specific to each region, the northern region has a higher proportion of chemical drugs, whereas the central and southern regions are the opposite of other regions, and the proportion of Chinese medicine is higher than that of the chemical.The central and southern region covers central and southern China, especially in southern China, where the traditional Chinese medicine is favored and the sales of Chinese medicine are more advantageous.
Figure 2. The proportion of western medicine in the key urban physical drug stores in the region in 16 years
The medicine of chronic disease and common disease is dominated by chemical medicine
In recent years, with the continuous improvement of living standards, the health awareness of residents is strengthening, and higher requirements for medical services and pharmaceutical services are also put forward.The number of retail pharmacies is large, and can be strong. It is conducive to health consultation, education and management and pharmaceutical services, which play a pivotal role in the health system of the national medicine.
Data show that chronic diseases and common diseases are more common in retail terminals.From the perspective of drug category, there are many types of drugs for chronic diseases and common diseases, such as cardiovascular system, digestive system and metabolic medicine, muscle-skeletal system, etc.In the top three categories of market share, the digestive system and the metabolite are the largest category of sales, the category mainly includes gastrointestinal medication, diabetes medication and so on.The cardiovascular system is ranked second in market share, and China's cardiovascular disease report 2016 indicates that the prevalence and mortality of cardiovascular disease in China are still rising.The disease has a longer duration and requires long-term use, so demand is growing.The body was ranked third with anti-infection-resistant drugs, which suffered a sustained decline in the market share of the country's "strictest restrictions in history".
In retail drug chemical medicine market, digestive and metabolic drugs, cardiovascular system, and the whole body with anti-infection drugs is one of the most important three big category, are the top three in four areas, but systemic anti-infection drugs in eastern and central south area sales fell.In addition, the musculoskeletal system has negative growth in the western region, and other major drugs are growing well in each region.
Table 1:16 years in the northern region of key urban physical pharmacy chemical drug category TOP10
Table 2:16 years in the eastern region of key urban physical drugstore chemical medicine category TOP10
Table 3:16 years in the western region of key urban physical drugstore chemical medicine category TOP10
Table 4:16 years, the major cities of central and south regions of the major cities of the chemical medicine category TOP10
The market for the respiratory system of the drug market is the first
Pharmacy proprietary Chinese medicine, according to data from 2016 key cities for the entity marketing top three category respectively respiratory system disease, musculoskeletal disease medication, diseases of the digestive system drugs, the three category accounted for nearly fifty percent of the market.Among them, the market share of the respiratory system disease drugs is the highest, leading among other categories, the absolute advantage.
Due to differences in population structure, economic development level and drug habit, the demand of Chinese medicine in the four regions is different in retail pharmacies.In the eastern and south-central regions, the consumption level is high, which pays more attention to health and health care, and the drug sales of bone and muscle system diseases are in the top three.In the northern and western regions of the relatively weak consumption level, there is a significant difference between the eastern and south-central regions of the drug structure, and the drug of the digestive system is relatively high.In addition, the third and fourth of the northern regions are the drug of bone muscle system and cardio-cerebrovascular disease, while the third and fourth in the west are the drugs for the use of air tonic and cardiovascular diseases.
Table 5:16 years in the northern region of key urban physical medicine drugstores in the major categories TOP10
Table 6:16 years in the eastern region of key urban physical medicine pharmacy of the drug category TOP10
Table 7:16 years in the western region of key urban physical medicine drugstores in the major categories TOP10
Table 8:16 years in the central and south regional key cities of the physical pharmacy of the pharmaceutical industry TOP10
Note: the data in this article does not include online pharmacies and non-pharmaceuticals
Data source: "competition pattern of key urban retail drugs in key cities"
|
| |
Previous article：Mobile healthcare in cooling: the battle for IP content in the head is intensifying
Next article：The household medical device market wins three elements
|
| |
|
|
